Global Antihypertensive Drugs Market Survey and Trend Research 2018

September 2018 | 67 pages | ID: GC94FD34265EN
99Strategy

Abstracts

Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Novartis, Pfizer, Johnson & Johnson, Sanofi, Ranbaxy Laboratories, Ranbaxy Laboratories, Merck, Astra Zeneca, Daiichi Sankyo, Takeda, Actelion, United Therapeutics etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Antihypertensive Drugs Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 ANTIHYPERTENSIVE DRUGS MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Novartis (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Pfizer (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Johnson & Johnson (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Sanofi (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Ranbaxy Laboratories (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Ranbaxy Laboratories (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Merck (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Astra Zeneca (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Daiichi Sankyo (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Takeda (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Actelion (Company Overview, Sales Data etc.)
4.12 United Therapeutics (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Antihypertensive Drugs Market 2012-2017, by Type, in USD Million
Table Global Antihypertensive Drugs Market Forecast 2018-2023, by Type, in USD Million
Table Novartis Overview List
Table Antihypertensive Drugs Business Operation of Novartis (Sales Revenue, Cost, Gross Margin)
Table Pfizer Overview List
Table Antihypertensive Drugs Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Antihypertensive Drugs Business Operation of Johnson & Johnson (Sales Revenue, Cost, Gross Margin)
Table Sanofi Overview List
Table Antihypertensive Drugs Business Operation of Sanofi (Sales Revenue, Cost, Gross Margin)
Table Ranbaxy Laboratories Overview List
Table Antihypertensive Drugs Business Operation of Ranbaxy Laboratories (Sales Revenue, Cost, Gross Margin)
Table Ranbaxy Laboratories Overview List
Table Antihypertensive Drugs Business Operation of Ranbaxy Laboratories (Sales Revenue, Cost, Gross Margin)
Table Merck Overview List
Table Antihypertensive Drugs Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
Table Astra Zeneca Overview List
Table Antihypertensive Drugs Business Operation of Astra Zeneca (Sales Revenue, Cost, Gross Margin)
Table Daiichi Sankyo Overview List
Table Antihypertensive Drugs Business Operation of Daiichi Sankyo (Sales Revenue, Cost, Gross Margin)
Table Takeda Overview List
Table Antihypertensive Drugs Business Operation of Takeda (Sales Revenue, Cost, Gross Margin)
Table Actelion Overview List
Table Antihypertensive Drugs Business Operation of Actelion (Sales Revenue, Cost, Gross Margin)
Table United Therapeutics Overview List
Table Antihypertensive Drugs Business Operation of United Therapeutics (Sales Revenue, Cost, Gross Margin)
Table Global Antihypertensive Drugs Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Antihypertensive Drugs Sales Revenue Share, by Companies, in USD Million
Table Antihypertensive Drugs Demand 2012-2017, by Application, in USD Million
Table Antihypertensive Drugs Demand Forecast 2018-2023, by Application, in USD Million
Table Global Antihypertensive Drugs Market 2012-2017, by Region, in USD Million
Table Antihypertensive Drugs Market Forecast 2018-2023, by Region, in USD Million

List Of Figures

LIST OF FIGURES

Figure Antihypertensive Drugs Industry Chain Structure
Figure Global Antihypertensive Drugs Market Growth 2012-2017, by Type, in USD Million
Figure Global Antihypertensive Drugs Sales Revenue Share, by Companies in 2017, in USD Million
Figure Production Development by Region
Figure Sales List by Region